Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-000435
Filing Date
2025-01-03
Accepted
2025-01-03 16:21:27
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form3-01032025_090124.html 3  
1 form3-01032025_090124.xml 3 2366
  Complete submission text file 0001415889-25-000435.txt   4253
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38114 | Film No.: 25506615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)